We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Biotech Growth Trust plc (The) (BIOG) Ordinary 25p

Sell:966.00p Buy:980.00p 0 Change: 22.00p (2.20%)
Market closed Prices as at close on 17 June 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:966.00p
Buy:980.00p
Change: 22.00p (2.20%)
Market closed Prices as at close on 17 June 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:966.00p
Buy:980.00p
Change: 22.00p (2.20%)
Market closed Prices as at close on 17 June 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
1,000.00p
Trade high:
1,006.00p
Year high:
1,048.00p
Estimated NAV:
1,068.92
Previous close:
1,002.00p
Trade low:
974.00p
Year low:
715.00p
Premium/Discount:
-6.26%
Previous:
22.00p (2.24%)
Previous:
22.00p
Volume:
282,848
Dividend yield:
n/a
Currency:
GBX
Data delayed by at least 15 minutes.

Price

  • Net Asset Value (NAV)
BIOTECH GWTH performance chart

Premium/Discount

BIOTECH GWTH performance chart
Full interactive share price and premium / discount charts

Performance

1 week 1W 1.87% 1 year 1Y 15.57%
1 month 1M 0.31% 2 years 2Y 21.29%
3 months 3M 2.73% 3 years 3Y 27.62%
6 months 6M 14.35% 5 years 5Y 35.36%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: NASDAQ Biotechnology TR GBP
Annual management charge: n/a
Performance fee: Yes
Ongoing charge: 1.30%
Dividend yield: n/a
Dividend frequency: None
Total assets: £363m
Gross gearing: 2%
Market capitalisation:Market cap.: £332m
Shares in issue: 33.09 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB0000385517

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents



Objective

The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.

NET ASSET VALUE (NAV)

Estimated NAV: 1,068.92
Latest actual NAV: 1,066.47
Latest actual NAV date: 14 June 2024
Premium/Discount: -6.26%
12m average Premium/Discount: -7.36%
NAV frequency: Daily
Security Weight
Amgen Inc 7.45%
Biogen Inc 6.35%
Janux Therapeutics Inc Ordinary Shares 6.17%
Regeneron Pharmaceuticals Inc 4.70%
Sarepta Therapeutics Inc 4.43%
Neurocrine Biosciences Inc 4.25%
Vaxcyte Inc Ordinary Shares 3.61%
Apellis Pharmaceuticals Inc 3.55%
Scholar Rock Holding Corp 3.34%
Ionis Pharmaceuticals Inc 3.06%
Sector Weight
Healthcare 106.07%
Country Weight
United States 98.14%
China 4.49%
Canada 1.90%
Germany 1.74%

Key Dates

Launch date: 23 June 1997
Financial year end: March
Next AGM: July 2024
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.